VitalsDaily.com
#hypertension_vascular_health

After Aortic Repair, AI Reads a Shifting Risk Map

Medically Reviewed by Dr. Şekip Altunkan on Jun 13, 2026.

Key Takeaway: Using data from over 12,000 patients, researchers have developed an AI model that can predict survival at 30 and 365 days following aortic aneurysm repair surgery. By identifying which risk factors are most critical and when, this tool opens the door to truly personalized postoperative monitoring, moving beyond one-size-fits-all follow-up protocols.

A Surgeon’s Crystal Ball

Imagine a 72-year-old man recovering from surgery to repair a dangerous bulge in his aorta. His surgeon faces a deceptively simple question: How closely should we monitor him over the next year? The current answer relies heavily on clinical intuition and broad population averages. But now, researchers using data from over 12,000 patients have developed an artificial intelligence model that can predict a patient’s long-term survival after aortic aneurysm surgery—and its answer is different for every individual.

An abdominal aortic aneurysm, a balloon-like bulge in the body’s largest artery, affects roughly 200,000 people in the United States annually and is responsible for an estimated 10,000 deaths each year[2]. Over the past two decades, endovascular aneurysm repair, known as EVAR, has become the dominant surgical approach, where a stent-graft is threaded through the femoral artery to reinforce the weakened aortic wall without the trauma of open surgery[3]. While EVAR has dramatically reduced short-term mortality, long-term outcomes remain stubbornly variable. Some patients thrive for years, while others face complications within months. The challenge lies in distinguishing these patients early enough to act.

Study Scope and Methods

A research team assembled a cohort of 12,312 patients who had undergone EVAR and applied multiple machine learning algorithms to their clinical data. The goal was to build a model that could predict survival at key postoperative time points, specifically at 30 and 365 days. They tested multiple algorithmic approaches and found that a ‘stacking ensemble’ model—a technique that combines the predictions of multiple individual algorithms to produce a single, more accurate output—exhibited the best predictive performance[1].

The model’s accuracy was assessed using a time-dependent concordance index, or C-index, which measures how well a model discriminates between patients who will and will not experience an event. On this index, a score of 0.5 is no better than a coin toss, while 1.0 signifies perfect prediction. The stacking ensemble model achieved a C-index of 0.759 at day 30 and 0.716 at day 365. These values indicate good discrimination and are competitive with, or superior to, many established clinical risk scores used in cardiovascular medicine[4].

Predictive Factors and Their Temporal Shifts

Perhaps the most clinically striking finding was not just what factors predicted mortality, but how their importance changed over time. In the early postoperative period, the dominant risk factors included age, kidney function (measured by creatinine or estimated glomerular filtration rate), and blood pressure. This is physiologically intuitive: the immediate stress of surgery taxes the kidneys and cardiovascular system, and older patients with diminished renal reserve are less able to tolerate the hemodynamic shifts during and after the procedure[5].

But as weeks turned into months, other factors came to the forefront. Smoking status, a known driver of endothelial dysfunction and ongoing aortic wall degradation, became increasingly important in the longer-term predictive window[6]. Similarly, household income—a proxy for social determinants of health that shape access to medications, follow-up appointments, and cardiac rehabilitation—also gained prominence. The finding that socioeconomic status independently predicts survival after a vascular procedure is sobering but not surprising; it reflects a growing body of literature showing that a patient’s zip code can be as potent a determinant of cardiovascular outcomes as their blood pressure[7].

This temporal shift in risk factors is a phenomenon that traditional risk calculators simply cannot capture. A static score, calculated on the day of surgery, treats the patient as a fixed entity. The machine learning model, in contrast, acknowledges that a patient’s risk profile is a moving target, shaped by biology in the initial weeks and increasingly by behavior and environment in the subsequent months.

Why This Matters for Future Patients

Currently, follow-up after EVAR adheres to a relatively rigid schedule: imaging at one, six, and twelve months, and annually thereafter. Roughly the same protocol is applied to every patient, whether they are a 60-year-old non-smoker with perfect kidney function or an 80-year-old diabetic with borderline renal failure. This is both wasteful for low-risk patients exposed to unnecessary CT scans, radiation, and contrast dye, and potentially insufficient for high-risk patients who might benefit from closer monitoring or earlier re-intervention.

A validated AI tool changes this equation. A low-risk patient could be safely placed on a less intensive follow-up schedule, reducing healthcare costs and personal burden. A high-risk patient could be flagged for more intensive surveillance, earlier imaging, or proactive management of modifiable risk factors like smoking cessation and blood pressure control. The model’s ability to identify when risk factors shift in importance could even guide the timing of specific interventions—for example, intensifying kidney-protective strategies in the first month and prioritizing smoking cessation programs in the months that follow.

Notable Limitations

No single study rewrites clinical practice, and this one has important caveats. While the cohort of 12,312 patients is substantial, the model’s generalizability to different populations, healthcare systems, and evolving surgical techniques must be tested through external validation. Machine learning models can also internalize biases present in the training data; if certain demographic groups are underrepresented, the model’s predictions for those patients may be less reliable. Furthermore, while a C-index of 0.716 at one year is good, it still leaves significant room for improvement. Finally, while the inclusion of household income as a predictor is statistically valid, it raises practical and ethical questions about how to use socioeconomic data in clinical decision-making without reinforcing existing inequities.

Final Assessment

It is important to emphasize here that while EVAR provides lower early mortality rates, it requires lifelong imaging surveillance and carries a significant long-term reintervention rate (around 15% at 3 years and up to one-third at 10 years). In many large studies, late survival is similar to or worse than open surgery. Durable exclusion of the aneurysm and strict surveillance are critical to preserving long-term outcomes after EVAR. In this regard, controlling hypertension and treating atherosclerosis and diabetes are essential and should not be neglected[8].

This research represents a significant step toward a future where postoperative care after aortic aneurysm repair is tailored to the individual, not the average. The model doesn’t replace surgical judgment; it augments it with a data-driven lens that can see patterns across thousands of patients simultaneously. For that 72-year-old patient recovering from EVAR, this means his follow-up plan could soon be built around his unique set of risks—and adjusted as those risks evolve over time. This is the promise of AI in medicine: not to replace the physician, but to give the physician a sharper instrument.


Scientific Sources

  1. Choi H, et al. Time-to-event ensemble machine learning approach for predicting long-term survival of abdominal aortic aneurysm patients undergoing endovascular aneurysm repair. PloS one. 2026;21(6):e0349122. PubMed: https://pubmed.ncbi.nlm.nih.gov/42284339/
  2. Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med. 2014;371(22):2101-2108.
  3. Greenhalgh RM, et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med. 2010;362(20):1863-1871.
  4. Alba AC, et al. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA. 2017;318(14):1377-1384.
  5. Saratzis, A, et al. Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2013;58 4: 879-85
  6. Lederle FA, et al. The aneurysm detection and management study screening program: validation cohort and final results. Arch Intern Med. 2000;160(10):1425-1430.
  7. Kelli HM, et al. Association between living in food deserts and cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2017;10(9):e003532.
  8. Cirillo-Penn NC, et al. Long Term Mortality and Reintervention Following Repair of Ruptured Abdominal Aortic Aneurysms using VQI Matched Medicare Claims. Ann Surg. 2023 Nov 1;278(5):e1135-e1141.

Medically reviewed by

Dr. Şekip Altunkan

Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."